328 related articles for article (PubMed ID: 29600358)
21. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
22. [Short-term outcomes of minimally invasive Sweet esophagectomy for Siewert type Ⅱ esophagogastric junction adenocarcinoma].
Liu CQ; Xie MR; Guo MF; Sun XH; Wu HR; Sun XX; Xu MQ
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):461-465. PubMed ID: 27938582
[No Abstract] [Full Text] [Related]
23. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
Moesta KT; Hünerbein M; Schlag PM
Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
[No Abstract] [Full Text] [Related]
24. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
Mönig SP; Schröder W; Beckurts KT; Hölscher AH
Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
[TBL] [Abstract][Full Text] [Related]
25. Inkwelling increases benign stricture formation after Ivor Lewis esophagogastrectomy.
Akowuah E; Junemann-Ramirez M; Kalejayie O; Rahamim J
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):581-2. PubMed ID: 17258611
[No Abstract] [Full Text] [Related]
26. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
27. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
Mazer LM; Poultsides GA
Surg Clin North Am; 2019 Jun; 99(3):457-469. PubMed ID: 31047035
[TBL] [Abstract][Full Text] [Related]
28. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
[TBL] [Abstract][Full Text] [Related]
29. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
[TBL] [Abstract][Full Text] [Related]
30. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
Hölscher AH; Fetzner UK
Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
[TBL] [Abstract][Full Text] [Related]
31. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
32. [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].
Hölscher AH; Bollschweiler E; Beckurts KT; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():169-72. PubMed ID: 9101821
[TBL] [Abstract][Full Text] [Related]
33. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
[TBL] [Abstract][Full Text] [Related]
34. [Whole laparoacopic trans-hiatal extended total gastrectomy with the Or-Vil device: preliminary results in the treatment of Siewert type II and III tumors].
Siani LM; Ferranti F; Marzano M; Benedetti M; Quintiliani A
Chir Ital; 2009; 61(3):289-94. PubMed ID: 19694230
[TBL] [Abstract][Full Text] [Related]
35. Gastrectomy compared to oesophagectomy for Siewert II and III gastro-oesophageal junctional cancer in relation to resection margins, lymphadenectomy and survival.
Kauppila JH; Wahlin K; Lagergren J
Sci Rep; 2017 Dec; 7(1):17783. PubMed ID: 29259274
[TBL] [Abstract][Full Text] [Related]
36. Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence.
Munitiz V; Ortiz A; Ruiz de Angulo D; F Martinez de Haro L; Parrilla P
Cir Esp (Engl Ed); 2019 Oct; 97(8):445-450. PubMed ID: 31027834
[TBL] [Abstract][Full Text] [Related]
37. Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction.
Jeremiasen M; Walther B; Djerf P; Staël von Holstein C; Zilling T; Hermansson M; Falkenback D; Johansson J
Am J Surg; 2019 Aug; 218(2):329-334. PubMed ID: 30635210
[TBL] [Abstract][Full Text] [Related]
38. Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis.
Heger P; Blank S; Gooßen K; Nienhüser H; Diener MK; Ulrich A; Mihaljevic AL; Schmidt T
Langenbecks Arch Surg; 2019 Feb; 404(1):103-113. PubMed ID: 30607534
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for Esophageal Adenocarcinoma.
Lam KO; Kwong DLW
Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
